Sun Pharma May Test Rs 760-780 on Downside: Aditya Agarwal
PUBLISHED ON: March 28, 2016 | Duration: 5 min, 46 sec
Aditya Agarwal, head technical research at Way2wealth, says Sun Pharma has closed below a crucial support at Rs 820 and selling pressure in the stock may continue going ahead. The shares may test Rs 780 levels in the short term, he adds.
